CN102755305A - 具有粘着层的经皮治疗系统,将该系统的背衬层加以硅氧烷化的方法以及该背衬层的用途 - Google Patents
具有粘着层的经皮治疗系统,将该系统的背衬层加以硅氧烷化的方法以及该背衬层的用途 Download PDFInfo
- Publication number
- CN102755305A CN102755305A CN2012102639862A CN201210263986A CN102755305A CN 102755305 A CN102755305 A CN 102755305A CN 2012102639862 A CN2012102639862 A CN 2012102639862A CN 201210263986 A CN201210263986 A CN 201210263986A CN 102755305 A CN102755305 A CN 102755305A
- Authority
- CN
- China
- Prior art keywords
- layer
- backing layer
- therapeutic system
- organopolysiloxane
- transcutaneous therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000010410 layer Substances 0.000 title claims abstract description 70
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims description 8
- 239000012790 adhesive layer Substances 0.000 title abstract 3
- 238000005475 siliconizing Methods 0.000 title 1
- 239000011241 protective layer Substances 0.000 claims abstract description 9
- 229920000642 polymer Polymers 0.000 claims abstract description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 46
- 239000011248 coating agent Substances 0.000 claims description 17
- 238000000576 coating method Methods 0.000 claims description 17
- 239000013047 polymeric layer Substances 0.000 claims description 15
- -1 polypropylene Polymers 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 8
- 229920000728 polyester Polymers 0.000 claims description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical group CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 229920005644 polyethylene terephthalate glycol copolymer Polymers 0.000 claims description 6
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 5
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 5
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 4
- 229920000573 polyethylene Polymers 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 3
- 229920000784 Nomex Polymers 0.000 claims description 3
- 229920001328 Polyvinylidene chloride Polymers 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- 229920006225 ethylene-methyl acrylate Polymers 0.000 claims description 3
- 125000000524 functional group Chemical group 0.000 claims description 3
- 239000004763 nomex Substances 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 239000005033 polyvinylidene chloride Substances 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- 229920000298 Cellophane Polymers 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical group CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000007942 carboxylates Chemical class 0.000 claims description 2
- 229920002301 cellulose acetate Polymers 0.000 claims description 2
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 claims description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 claims description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 claims 1
- 239000011347 resin Substances 0.000 claims 1
- 229920005573 silicon-containing polymer Polymers 0.000 claims 1
- 229920002050 silicone resin Polymers 0.000 claims 1
- 125000005375 organosiloxane group Chemical group 0.000 abstract 1
- 239000010408 film Substances 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229940117958 vinyl acetate Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/023—Adhesive bandages or dressings wound covering film layers without a fluid retention layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0246—Adhesive bandages or dressings characterised by the skin-adhering layer
- A61F13/0253—Adhesive bandages or dressings characterised by the skin-adhering layer characterized by the adhesive material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/34—Silicon-containing compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0246—Adhesive bandages or dressings characterised by the skin-adhering layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004044578A DE102004044578A1 (de) | 2004-09-13 | 2004-09-13 | Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht |
| DE102004044578.8 | 2004-09-13 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2005800305367A Division CN101018545A (zh) | 2004-09-13 | 2005-09-06 | 具有粘着层的经皮治疗系统,将该系统的背衬层加以硅氧烷化的方法以及该背衬层的用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102755305A true CN102755305A (zh) | 2012-10-31 |
Family
ID=35911201
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102639862A Pending CN102755305A (zh) | 2004-09-13 | 2005-09-06 | 具有粘着层的经皮治疗系统,将该系统的背衬层加以硅氧烷化的方法以及该背衬层的用途 |
| CNA2005800305367A Pending CN101018545A (zh) | 2004-09-13 | 2005-09-06 | 具有粘着层的经皮治疗系统,将该系统的背衬层加以硅氧烷化的方法以及该背衬层的用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2005800305367A Pending CN101018545A (zh) | 2004-09-13 | 2005-09-06 | 具有粘着层的经皮治疗系统,将该系统的背衬层加以硅氧烷化的方法以及该背衬层的用途 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US9226903B2 (enExample) |
| EP (2) | EP2529732B1 (enExample) |
| JP (1) | JP4921371B2 (enExample) |
| KR (1) | KR101297903B1 (enExample) |
| CN (2) | CN102755305A (enExample) |
| AR (1) | AR050621A1 (enExample) |
| AU (1) | AU2005284436B2 (enExample) |
| BR (1) | BRPI0515270B8 (enExample) |
| CA (1) | CA2578534C (enExample) |
| CY (2) | CY1113997T1 (enExample) |
| DE (1) | DE102004044578A1 (enExample) |
| DK (2) | DK1791533T3 (enExample) |
| ES (2) | ES2406958T3 (enExample) |
| IL (1) | IL181337A (enExample) |
| LT (1) | LT2529732T (enExample) |
| MX (1) | MX2007002966A (enExample) |
| NZ (1) | NZ553485A (enExample) |
| PH (1) | PH12012501165A1 (enExample) |
| PL (2) | PL1791533T3 (enExample) |
| PT (2) | PT2529732T (enExample) |
| RU (1) | RU2398567C2 (enExample) |
| SI (2) | SI1791533T1 (enExample) |
| TW (1) | TWI383811B (enExample) |
| WO (1) | WO2006029740A2 (enExample) |
| ZA (1) | ZA200701138B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| CA2580329C (en) | 2004-09-13 | 2015-01-06 | Chrono Therapeutics Inc. | Biosynchronous transdermal drug delivery |
| US8518926B2 (en) * | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
| US20070259930A1 (en) * | 2006-04-10 | 2007-11-08 | Knopp Neurosciences, Inc. | Compositions and methods of using r(+) pramipexole |
| ES2379117T3 (es) * | 2006-05-16 | 2012-04-20 | Knopp Neurosciences, Inc. | Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas |
| US8524695B2 (en) * | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
| WO2008113056A2 (en) | 2007-03-14 | 2008-09-18 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
| CN102186350A (zh) * | 2008-08-19 | 2011-09-14 | 诺普神经科学股份有限公司 | 使用(r)-普拉克索的组合物与方法 |
| US20110009460A1 (en) * | 2009-06-19 | 2011-01-13 | Valentin Gribkoff | Compositions and methods for treating amyotrophic lateral sclerosis |
| US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
| WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
| KR101850161B1 (ko) | 2012-05-17 | 2018-04-19 | 도레이첨단소재 주식회사 | 경피흡수제에 적합하게 사용될 수 있는 릴리즈 라이너 및 그 제조방법 |
| US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
| US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
| SMT202100119T1 (it) | 2013-07-12 | 2021-05-07 | Knopp Biosciences Llc | Trattamento dei livelli elevati di eosinofili e/o basofili |
| AU2014306597B2 (en) | 2013-08-13 | 2018-05-17 | Knopp Biosciences Llc | Compositions and methods for treating chronic urticaria |
| EP3038467B1 (en) | 2013-08-13 | 2020-07-29 | Knopp Biosciences LLC | Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders |
| US9827206B2 (en) * | 2013-09-24 | 2017-11-28 | Zodiac Coating | Method for producing an adhesive material for medical application |
| EP2921184A1 (de) * | 2014-03-19 | 2015-09-23 | LTS LOHMANN Therapie-Systeme AG | Überpflaster mit verbesserter Verträglichkeit und einer langen Haftungsdauer und Verfahren zu seiner Herstellung |
| CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
| WO2016145373A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
| EP3565617A1 (en) | 2017-01-06 | 2019-11-13 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
| US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| CA3119992A1 (en) | 2018-11-16 | 2020-05-22 | Morningside Venture Investments Limited | Thermally regulated transdermal drug delivery system |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3131734A1 (de) * | 1981-08-11 | 1983-02-24 | Bayer Ag, 5090 Leverkusen | Hitzehaertbare organopolysiloxan-mischungen |
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| FR2619388A1 (fr) * | 1987-08-14 | 1989-02-17 | Rhone Poulenc Chimie | Article stratifie souple pour adhesif de transfert |
| DE19738643C2 (de) | 1997-09-04 | 2001-10-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung |
| US6433054B1 (en) * | 1997-09-16 | 2002-08-13 | Teijin Limited | Gel-form pressure-sensitive adhesive, and adhesive material and adhesive medicinal preparation both containing the same |
| PL197492B1 (pl) * | 1999-07-02 | 2008-04-30 | Lohmann Therapie Syst Lts | Transdermalny system terapeutyczny zawierający warstwę polimerową z zawartymi w niej mikrozbiornikami i sposób wytwarzania błon |
| US6261595B1 (en) | 2000-02-29 | 2001-07-17 | Zars, Inc. | Transdermal drug patch with attached pocket for controlled heating device |
| DE10015783C2 (de) * | 2000-03-30 | 2003-12-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Abgabe von Lerisetron und seine Verwendung |
| US6488599B2 (en) | 2000-06-06 | 2002-12-03 | Lifetime Products, Inc. | System and method for basketball goal height adjustment |
| GB0017468D0 (en) * | 2000-07-18 | 2000-08-30 | Dow Corning | Silicone release coating compositions |
| DE10060550C1 (de) * | 2000-12-06 | 2002-04-18 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten |
| US20030224090A1 (en) * | 2002-02-11 | 2003-12-04 | Edizone, Lc | Snacks of orally soluble edible films |
| ITRM20020378A1 (it) | 2002-07-15 | 2004-01-15 | Euro 3 S R L | Dispositivo iniettore ipodermico attivabile. |
| RU2348397C2 (ru) * | 2003-02-07 | 2009-03-10 | Лтс Ломанн Терапи-Системе Аг | Трансдермальная терапевтическая система, пригодная для использования тепла с целью ускорения проникновения биологически активных веществ, и ее применение |
| RU2349315C9 (ru) * | 2003-04-14 | 2010-02-27 | Лтс Ломанн Терапи-Системе Аг | Терапевтический пластырь с полисилоксановой матрицей, содержащей капсаицин |
| US7407709B2 (en) * | 2003-12-22 | 2008-08-05 | 3M Innovative Properties Company | Silicone pressure sensitive adhesive and articles |
| JP5525121B2 (ja) * | 2003-12-23 | 2014-06-18 | モーメンテイブ・パーフオーマンス・マテリアルズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | 表面の性質の改変された硬化型シロキサン組成物 |
| US20050282977A1 (en) * | 2004-06-17 | 2005-12-22 | Emil Stempel | Cross-linked gel and pressure sensitive adhesive blend, and skin-attachable products using the same |
-
2004
- 2004-09-13 DE DE102004044578A patent/DE102004044578A1/de not_active Ceased
-
2005
- 2005-08-30 AR ARP050103629A patent/AR050621A1/es active IP Right Grant
- 2005-09-02 TW TW094130154A patent/TWI383811B/zh not_active IP Right Cessation
- 2005-09-06 BR BRPI0515270A patent/BRPI0515270B8/pt active IP Right Grant
- 2005-09-06 EP EP12006147.8A patent/EP2529732B1/de not_active Expired - Lifetime
- 2005-09-06 SI SI200531700T patent/SI1791533T1/sl unknown
- 2005-09-06 RU RU2007113674/15A patent/RU2398567C2/ru active
- 2005-09-06 DK DK05777179.2T patent/DK1791533T3/da active
- 2005-09-06 ES ES05777179T patent/ES2406958T3/es not_active Expired - Lifetime
- 2005-09-06 SI SI200532168T patent/SI2529732T1/sl unknown
- 2005-09-06 EP EP05777179A patent/EP1791533B1/de not_active Expired - Lifetime
- 2005-09-06 PT PT120061478T patent/PT2529732T/pt unknown
- 2005-09-06 DK DK12006147.8T patent/DK2529732T3/en active
- 2005-09-06 CN CN2012102639862A patent/CN102755305A/zh active Pending
- 2005-09-06 WO PCT/EP2005/009547 patent/WO2006029740A2/de not_active Ceased
- 2005-09-06 NZ NZ553485A patent/NZ553485A/en not_active IP Right Cessation
- 2005-09-06 PT PT57771792T patent/PT1791533E/pt unknown
- 2005-09-06 CA CA2578534A patent/CA2578534C/en not_active Expired - Lifetime
- 2005-09-06 US US11/661,530 patent/US9226903B2/en active Active
- 2005-09-06 ES ES12006147.8T patent/ES2634439T3/es not_active Expired - Lifetime
- 2005-09-06 KR KR1020077005735A patent/KR101297903B1/ko not_active Expired - Lifetime
- 2005-09-06 PL PL05777179T patent/PL1791533T3/pl unknown
- 2005-09-06 MX MX2007002966A patent/MX2007002966A/es active IP Right Grant
- 2005-09-06 PH PH1/2012/501165A patent/PH12012501165A1/en unknown
- 2005-09-06 PL PL12006147T patent/PL2529732T3/pl unknown
- 2005-09-06 LT LTEP12006147.8T patent/LT2529732T/lt unknown
- 2005-09-06 JP JP2007530634A patent/JP4921371B2/ja not_active Expired - Lifetime
- 2005-09-06 CN CNA2005800305367A patent/CN101018545A/zh active Pending
- 2005-09-06 AU AU2005284436A patent/AU2005284436B2/en not_active Expired
-
2007
- 2007-02-08 ZA ZA200701138A patent/ZA200701138B/xx unknown
- 2007-02-14 IL IL181337A patent/IL181337A/en active IP Right Grant
-
2013
- 2013-05-16 CY CY20131100401T patent/CY1113997T1/el unknown
-
2015
- 2015-11-30 US US14/953,789 patent/US10034841B2/en not_active Expired - Lifetime
-
2017
- 2017-09-13 CY CY20171100968T patent/CY1120228T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755305A (zh) | 具有粘着层的经皮治疗系统,将该系统的背衬层加以硅氧烷化的方法以及该背衬层的用途 | |
| CN100423784C (zh) | 皮肤贴敷用压敏粘合剂片 | |
| US5498417A (en) | Transdermal delivery of appetite suppressant drug | |
| JP2008512411A5 (enExample) | ||
| KR20010111593A (ko) | 신축성 첩부제 | |
| KR20070110093A (ko) | 비섬유성 경피 치료 시스템 및 그 제조방법 | |
| KR101017882B1 (ko) | 가교형 피부용 점착제 | |
| JP2003507417A (ja) | 少なくとも二つのポリマー含有層を含む、皮膚に塗布するための活性物質含有治療システム | |
| TWI280126B (en) | Tulobuterol adhesive patch | |
| JP2001512465A (ja) | 物理的特性の改善されたポリアクリレートマトリックスを有する経皮吸収または局所プラスターシステム | |
| BR112020021173A2 (pt) | Sistema terapêutico transdérmico para a administração transdérmica de solifenacina | |
| CN108753219B (zh) | 一种低温型双亲性苯乙烯系热熔压敏胶、制备方法及其应用 | |
| HK1175110A (en) | Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer | |
| HK1105360A (en) | Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer | |
| JP4372882B2 (ja) | 貼付材用基材およびそれを用いてなる医療用貼付材、ならびに救急絆創膏 | |
| JPWO2004089347A1 (ja) | ツロブテロール含有経皮吸収製剤およびこれを使用する貼付剤 | |
| CN108601749A (zh) | 具有氟代硅氧烷剥离衬件的透皮药物递送体系 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1175110 Country of ref document: HK |
|
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121031 |